ArticleJournal of the Chinese Medical Association : JCMA2022

Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shunt.

Pin-Ko Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.